Clinical Trial Update: The Food Effect on PK Characteristics and Safety Profiles of PA-111 [Phase 1]

View source ↗

Summary

Phase 1 clinical trial update evaluating the effect of food on the pharmacokinetics and safety of PA-111 in patients with Mixed Dyslipidemia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Mixed Dyslipidemia

Drugs mentioned

• PA-111

Snippet

Sponsor: Addpharma Inc. | Conditions: Mixed Dyslipidemia | Phase 1 | Status: NOT_YET_RECRUITING